Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology

Roberto Salgado*, David B. Solit, David L. Rimm, Jan Bogaerts, Renzo Canetta, Tracy Lively, Kim Lyerly, Paul N. Span, Alison Bateman-House, Amr Makady, L. Bergmann, Sumimasa Nagai, Chris Smith, Mark Robson, Mary Savage, Emile Voest, Christopher Sweeney, Philippe Lambin, Marlene Thomas, Lyndsay HarrisDenis Lacombe, Chistophe Massard, Herbert K. Lyerly, Laura Yee, David Rimm, Alison Bateman-Houseaj, Lothar Bergmann, Sumimasa Nagaiam, Marlene Thomasan, Ian A. Cree, Shirley Hopper, Marc Robson, Magnus Ingelman-Sundberg, Francois Maignen, Benjamin Besse, Rafal Swierzewski, Astrid Kiermaier, Denis Lacombex, Tracy Livelyad, Christophe Massard, Roberto Salgadobf, Vassilis Golfinopoulos, IBCD Fac

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)128-136
Number of pages9
JournalEuropean Journal of Cancer
Volume114
DOIs
Publication statusPublished - Jun 2019

Keywords

  • Biomarkers
  • Evidence-driven optimal health-care delivery
  • Molecular and immunologic profiling
  • Health technology assessment
  • Clinical trials
  • GUIDELINES
  • ACCESS

Cite this

Salgado, R., Solit, D. B., Rimm, D. L., Bogaerts, J., Canetta, R., Lively, T., Lyerly, K., Span, P. N., Bateman-House, A., Makady, A., Bergmann, L., Nagai, S., Smith, C., Robson, M., Savage, M., Voest, E., Sweeney, C., Lambin, P., Thomas, M., ... IBCD Fac (2019). Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology. European Journal of Cancer, 114, 128-136. https://doi.org/10.1016/j.ejca.2019.03.025